Shooting the messenger (RNA) in B-cell lymphoma

摘要

In this issue of Blood, Culjkovic-Kraljacic et al demonstrate that targeted inhibition of the messenger RNA (mRNA) translation initiation factor eIF4E is an effective strategy to reduce expression of the MYC, B-cell lymphoma (BCL) 2, and BCL6 oncoproteins in aggressive BCLs.